We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.34%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.05B
AUM Growth
+$688M
(+11%)
Cap. Flow
+$306M
Cap. Flow
% of AUM
4.35%
Top 10 Holdings %
Top 10 Hldgs %
15.99%
Holding
1,149
New
136
Increased
453
Reduced
359
Closed
174
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$40.4M |
| 2 |
Amazon
AMZN
|
+$35M |
| 3 |
TJX Companies
TJX
|
+$34.6M |
| 4 |
Phillips 66
PSX
|
+$33.1M |
| 5 |
Mastercard
MA
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$31.7M |
| 2 |
Cigna
CI
|
+$27.3M |
| 3 |
Meta Platforms (Facebook)
META
|
+$21.6M |
| 4 |
JPMorgan Chase
JPM
|
+$21M |
| 5 |
Marvell Technology
MRVL
|
+$20.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.29% |
| 2 | Financials | 17.18% |
| 3 | Consumer Discretionary | 12.24% |
| 4 | Industrials | 11.66% |
| 5 | Healthcare | 10.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UFS
201
DELISTED
DOMTAR CORPORATION (New)
UFS
| $8.48M | 0.12% |
162,554
+108,124
| +199% | +$5.45M |
|
202
Charles River Laboratories
CRL
$10.9B
| $8.44M | 0.12% |
62,752
+41,922
| +201% | +$5.17M |
|
203
Forward Air
FWRD
$482M
| $8.44M | 0.12% |
117,686
+1,657
| +1% | +$105K |
|
204
CNO Financial Group
CNO
$4.97B
| $8.41M | 0.12% |
396,227
-97,100
| -20% | -$2.04M |
|
|
WCC
205
WESCO International
WCC
$16.2B
| $8.4M | 0.12% |
136,638
+9,748
| +8% | +$584K |
|
206
AXIS Capital
AXS
$8.59B
| $8.38M | 0.12% |
145,219
-50,013
| -26% | -$2.83M |
|
207
Rayonier
RYN
$6.49B
| $8.24M | 0.12% |
268,620
+6,460
| +2% | +$207K |
|
208
Lattice Semiconductor
LSCC
$17.6B
| $8.22M | 0.12% |
1,027,352
-74,149
| -7% | -$548K |
|
|
EFII
209
DELISTED
Electronics for Imaging
EFII
| $8.18M | 0.12% |
240,019
-20,732
| -8% | -$703K |
|
|
TEN
210
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $8.15M | 0.12% |
193,298
-121,439
| -39% | -$5.33M |
|
211
Genesco
GCO
$396M
| $7.97M | 0.11% |
169,246
+22,742
| +16% | +$993K |
|
212
Merck
MRK
$324B
| $7.96M | 0.11% |
117,650
-77,866
| -40% | -$4.96M |
|
213
Benchmark Electronics
BHE
$2.91B
| $7.93M | 0.11% |
339,044
+157,196
| +86% | +$4.15M |
|
214
Varonis Systems
VRNS
$5.25B
| $7.87M | 0.11% |
322,158
+11,136
| +4% | +$270K |
|
215
American Homes 4 Rent
AMH
$12B
| $7.8M | 0.11% |
356,447
-59,153
| -14% | -$1.34M |
|
216
LKQ Corp
LKQ
$6.58B
| $7.8M | 0.11% |
246,281
-240,193
| -49% | -$7.98M |
|
217
Adtran
ADTN
$798M
| $7.79M | 0.11% |
441,584
+75,825
| +21% | +$1.27M |
|
218
Herbalife
HLF
$1.23B
| $7.78M | 0.11% |
142,610
+97,480
| +216% | +$5.38M |
|
219
Workiva
WK
$2.94B
| $7.73M | 0.11% |
195,637
-24,503
| -11% | -$762K |
|
220
Cullen/Frost Bankers
CFR
$10.3B
| $7.69M | 0.11% |
73,609
+18,759
| +34% | +$2.08M |
|
221
LivePerson
LPSN
$18.9M
| $7.68M | 0.11% |
19,730
+2,827
| +17% | +$1.04M |
|
222
CF Industries
CF
$19.2B
| $7.6M | 0.11% |
139,614
+87,724
| +169% | +$4.23M |
|
223
Visa
V
$677B
| $7.55M | 0.11% |
50,320
+38,020
| +309% | +$5.41M |
|
224
Conagra Brands
CAG
$7.07B
| $7.55M | 0.11% |
222,220
-221,160
| -50% | -$8.08M |
|
|
ATH
225
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $7.54M | 0.11% |
145,962
-151,252
| -51% | -$7.29M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2018 Portfolio in Review
As of Q3 2018, Jacobs Levy Equity Management held 1,149 positions worth $7.05B, up 11% from $6.36B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Jacobs Levy Equity Management deployed $306M of net new capital in Q3 2018, opening 136 new positions and adding to 453 existing holdings. Its largest new stake was TJX Companies: 673,440 shares worth $37.7M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Eli Lilly, an estimated $31.7M trimmed.
- Jacobs Levy Equity Management's largest Q3 2018 buy was TJX Companies: 673,440 shares worth $37.7M.
- Jacobs Levy Equity Management added most to Alphabet (Google) Class C in Q3 2018, an estimated $40.4M increase.
- Jacobs Levy Equity Management's biggest Q3 2018 reduction was Eli Lilly, cutting an estimated $31.7M.
- Jacobs Levy Equity Management fully exited Dun & Bradstreet in Q3 2018, selling an estimated $17.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 16% of its $7.05B portfolio in Q3 2018.
- Jacobs Levy Equity Management opened 136 new positions and closed 174 in Q3 2018.
- Jacobs Levy Equity Management's portfolio value rose 11% quarter-over-quarter to $7.05B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2018, filed 14 Nov 2018.